FASN and metabolic dysfunction-associated steatotic liver disease: In contrast to its expression in most normal tissues, FASN is overexpressed in several cancers (43, –, 47), diabetes (48, 49), obesity (49), and non-alcoholic fatty liver disease (NAFLD) (50, 51).